Corline Biomedical AB's total assets for Q2 2025 were kr86.35M, a decrease of -3.59% from the previous quarter. SE:CLBIO total liabilities were kr5.76M for the fiscal quarter, a 0.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.